| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.1 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.1 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.1 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.1 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.1 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |